Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)
Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%
Zoetis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zoetis's operating cash flow for the twelve months ending Jun 30, 2026 was $2.84B, down 4.6% year over year. For fiscal 2025 it was $2.90B, down 1.7% from the year before. Over ten years it grew 15.9% a year on average. The highest annual figure on record is $2.95B in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.90B | -1.7% |
| FY2024 | Dec 31, 2024 | $2.95B | +25.5% |
| FY2023 | Dec 31, 2023 | $2.35B | +23.1% |
| FY2022 | Dec 31, 2022 | $1.91B | -13.6% |
| FY2021 | Dec 31, 2021 | $2.21B | +4.1% |
| FY2020 | Dec 31, 2020 | $2.13B | +18.4% |
| FY2019 | Dec 31, 2019 | $1.80B | +0.3% |
| FY2018 | Dec 31, 2018 | $1.79B | +33.0% |
| FY2017 | Dec 31, 2017 | $1.35B | +88.8% |
| FY2016 | Dec 31, 2016 | $713.00M | +7.4% |
| FY2015 | Dec 31, 2015 | $664.00M | +6.1% |
| FY2014 | Dec 31, 2014 | $626.00M | -8.1% |
| FY2013 | Dec 31, 2013 | $681.00M | +50.0% |
| FY2012 | Dec 31, 2012 | $454.00M | -8.7% |
| FY2011 | Dec 31, 2011 | $497.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $655.00M | +8.3% |
| Q1 FY2026 | Mar 31, 2026 | $401.00M | -22.1% |
| Q4 FY2025 | Dec 31, 2025 | $893.00M | -1.3% |
| Q3 FY2025 | Sep 30, 2025 | $891.00M | -6.3% |
| Q2 FY2025 | Jun 30, 2025 | $605.00M | +20.5% |
| Q1 FY2025 | Mar 31, 2025 | $515.00M | -13.4% |
| Q4 FY2024 | Dec 31, 2024 | $905.00M | +0.9% |
| Q3 FY2024 | Sep 30, 2024 | $951.00M | +31.4% |
| Q2 FY2024 | Jun 30, 2024 | $502.00M | +174.3% |
| Q1 FY2024 | Mar 31, 2024 | $595.00M | +8.4% |
| Q4 FY2023 | Dec 31, 2023 | $897.00M | +21.1% |
| Q3 FY2023 | Sep 30, 2023 | $724.00M | +37.6% |
| Q2 FY2023 | Jun 30, 2023 | $183.00M | -45.5% |
| Q1 FY2023 | Mar 31, 2023 | $549.00M | +77.7% |
| Q4 FY2022 | Dec 31, 2022 | $741.00M | +9.1% |
| Q3 FY2022 | Sep 30, 2022 | $526.00M | -19.4% |
| Q2 FY2022 | Jun 30, 2022 | $336.00M | -30.1% |
| Q1 FY2022 | Mar 31, 2022 | $309.00M | -22.8% |
| Q4 FY2021 | Dec 31, 2021 | $679.00M | -5.4% |
| Q3 FY2021 | Sep 30, 2021 | $653.00M | +16.2% |
| Q2 FY2021 | Jun 30, 2021 | $481.00M | +9.8% |
| Q1 FY2021 | Mar 31, 2021 | $400.00M | -2.0% |
| Q4 FY2020 | Dec 31, 2020 | $718.00M | +23.4% |
| Q3 FY2020 | Sep 30, 2020 | $562.00M | +11.1% |
| Q2 FY2020 | Jun 30, 2020 | $438.00M | +37.7% |
| Q1 FY2020 | Mar 31, 2020 | $408.00M | +4.9% |
| Q4 FY2019 | Dec 31, 2019 | $582.00M | -0.3% |
| Q3 FY2019 | Sep 30, 2019 | $506.00M | -8.0% |
| Q2 FY2019 | Jun 30, 2019 | $318.00M | +19.1% |
| Q1 FY2019 | Mar 31, 2019 | $389.00M | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | $584.00M | -3.9% |
| Q3 FY2018 | Sep 30, 2018 | $550.00M | +25.3% |
| Q2 FY2018 | Jun 30, 2018 | $267.00M | +48.3% |
| Q1 FY2018 | Mar 31, 2018 | $389.00M | +226.9% |
| Q4 FY2017 | Dec 31, 2017 | $608.00M | +112.6% |
| Q3 FY2017 | Oct 1, 2017 | $439.00M | +83.7% |
| Q2 FY2017 | Jul 2, 2017 | $180.00M | – |
| Q1 FY2017 | Apr 2, 2017 | $119.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $286.00M | – |
| Q3 FY2016 | Oct 2, 2016 | $239.00M | – |
See a number that looks wrong?